Desh Rakshak Aushdhalaya (BSE 531521)₹24.500.00%Pharmaceuticals
In the Mar 2026 quarter (standalone), Desh Rakshak Aushdhalaya reported sales of ₹3.44 Cr, down 21.5% from Mar 2025, and net profit of ₹0.29 Cr, down 17.1% year on year. For the year to Mar 2026, sales were ₹7.09 Cr and net profit ₹0.55 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.10 | 0.83 | 1.57 | 2.48 | 1.07 | 1.18 | 1.87 | 4.38 | 1.29 | 0.94 | 1.39 | 3.44 |
| Expenses | 0.88 | 0.53 | 1.28 | 2.08 | 0.82 | 0.86 | 1.60 | 3.44 | 1.06 | 0.69 | 1.15 | 2.83 |
| Operating Profit | 0.25 | 0.33 | 0.32 | 0.43 | 0.28 | 0.33 | 0.30 | 0.97 | 0.26 | 0.28 | 0.27 | 0.64 |
| OPM % | 21.6% | 38.1% | 19.6% | 16.8% | 24.9% | 28.5% | 15.4% | 21.8% | 19.2% | 28.4% | 18.5% | 18.2% |
| Other Income | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.04 | 0.11 | 0.10 | 0.08 | 0.06 | 0.07 | 0.09 | 0.23 | 0.04 | 0.09 | 0.05 | 0.11 |
| Depreciation | 0.10 | 0.12 | 0.10 | 0.12 | 0.10 | 0.12 | 0.12 | 0.30 | 0.11 | 0.11 | 0.11 | 0.14 |
| Profit before tax | 0.07 | 0.08 | 0.12 | 0.23 | 0.08 | 0.14 | 0.11 | 0.43 | 0.09 | 0.08 | 0.09 | 0.40 |
| Tax % | 0.0% | 0.0% | 0.0% | 33.4% | 0.0% | 0.0% | 0.0% | 20.5% | 0.0% | 0.0% | 0.0% | 26.9% |
| Net Profit | 0.07 | 0.08 | 0.12 | 0.15 | 0.08 | 0.14 | 0.11 | 0.35 | 0.09 | 0.07 | 0.08 | 0.29 |
| EPS (Rs) | 0.19 | 0.21 | 0.30 | 0.37 | 0.21 | 0.35 | 0.28 | 0.82 | 0.24 | 0.15 | 0.17 | 0.54 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.97 | 5.04 | 5.04 | 5.49 | 5.05 | 6.55 | 6.13 | 6.12 | 5.94 | 6.16 | 7.09 | 7.06 |
| Expenses | 4.27 | 4.40 | 4.35 | 4.74 | 4.28 | 5.63 | 4.95 | 4.75 | 4.67 | 4.93 | 5.73 | 5.73 |
| Operating Profit | 0.73 | 0.67 | 0.72 | 0.77 | 0.80 | 0.96 | 1.21 | 1.40 | 1.30 | 1.27 | 1.39 | 1.45 |
| OPM % | 14.4% | 13.0% | 14.0% | 14.1% | 15.6% | 14.4% | 19.5% | 22.7% | 21.6% | 20.4% | 19.4% | 20.5% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | −0.04 | 0.01 | 0.02 | 0.00 | 0.00 |
| Interest | 0.10 | 0.12 | 0.14 | 0.14 | 0.15 | 0.15 | 0.25 | 0.43 | 0.38 | 0.32 | 0.29 | 0.29 |
| Depreciation | 0.23 | 0.23 | 0.25 | 0.26 | 0.28 | 0.27 | 0.41 | 0.45 | 0.45 | 0.41 | 0.45 | 0.47 |
| Profit before tax | 0.37 | 0.33 | 0.34 | 0.40 | 0.36 | 0.54 | 0.56 | 0.47 | 0.49 | 0.55 | 0.66 | 0.66 |
| Tax % | 23.7% | 17.7% | 20.1% | 19.6% | 19.0% | 23.7% | 15.9% | 14.7% | 16.1% | 16.1% | 16.5% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.04 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.28 | 0.27 | 0.27 | 0.33 | 0.29 | 0.41 | 0.47 | 0.40 | 0.42 | 0.47 | 0.55 | 0.53 |
| EPS (Rs) | 0.66 | 0.64 | 0.64 | 0.78 | 0.69 | 0.96 | 1.09 | 0.93 | 0.98 | 1.09 | 0.99 | 1.10 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.65 | 4.66 | 4.66 | 4.66 | 4.66 | 5.91 |
| Reserves | 2.15 | 2.46 | 2.74 | 3.02 | 3.45 | 3.72 | 4.14 | 4.63 | 4.48 | 4.83 | 5.30 | 7.37 |
| Borrowings | 1.05 | 1.46 | 0.68 | 0.95 | 1.22 | 2.02 | 2.89 | 4.30 | 4.09 | 2.77 | 3.03 | 2.79 |
| Other Liabilities | 1.70 | 1.48 | 2.06 | 2.15 | 2.00 | 1.90 | 2.86 | 2.51 | 2.49 | 4.04 | 4.96 | 4.78 |
| Total Liabilities | 9.56 | 10.06 | 10.14 | 10.78 | 11.33 | 12.30 | 14.54 | 16.10 | 15.72 | 16.30 | 17.95 | 20.85 |
| Fixed Assets | 3.68 | 3.74 | 3.86 | 3.92 | 4.38 | 5.37 | 6.48 | 7.81 | 8.06 | 7.67 | 7.83 | 8.19 |
| CWIP | 1.34 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 1.86 | 1.38 |
| Investments | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Other Assets | 4.41 | 3.83 | 3.79 | 4.37 | 4.46 | 4.44 | 5.64 | 5.87 | 5.24 | 6.21 | 8.20 | 11.22 |
| Inventories | 1.42 | 1.14 | 1.28 | 1.32 | 0.89 | 0.80 | 0.68 | 0.84 | 0.80 | 0.31 | 0.18 | 0.26 |
| Trade receivables | 1.56 | 1.72 | 2.04 | 2.49 | 2.97 | 3.08 | 3.87 | 3.98 | 3.65 | 5.14 | 7.37 | 9.19 |
| Cash & equivalents | 0.26 | 0.87 | 0.34 | 0.30 | 0.17 | 0.23 | 0.60 | 0.24 | 0.06 | 0.15 | 0.08 | 0.16 |
| Total Assets | 9.56 | 10.06 | 10.14 | 10.78 | 11.33 | 12.30 | 14.54 | 16.10 | 15.72 | 16.30 | 17.95 | 20.85 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.26 | 1.26 | 0.22 | −0.14 | −0.54 | 0.58 | 0.83 | 0.22 | 0.44 | 1.51 | −0.29 | −1.30 |
| Cash from investing activity | −0.44 | −0.65 | −0.75 | 0.03 | 0.41 | −1.26 | −1.25 | −1.94 | −0.77 | −0.08 | −0.01 | −1.63 |
| Cash from financing activity | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.73 | 0.79 | 1.34 | 0.14 | −1.33 | 0.24 | 3.01 |
| Net cash flow | −0.17 | 0.60 | −0.52 | −0.03 | −0.11 | 0.05 | 0.36 | −0.35 | −0.17 | 0.08 | −0.06 | 0.07 |
| Capex | 0.50 | 1.06 | 0.33 | 0.00 | 0.00 | 1.24 | 1.37 | 1.73 | 0.79 | 0.04 | 0.56 | 1.49 |
| Free cash flow | −0.25 | 0.21 | −0.12 | 0.26 | 0.08 | −0.67 | −0.55 | −1.52 | −0.21 | 1.48 | −0.38 | −2.82 |
| CFO / OP % | 41.9% | 187.9% | 44.0% | −11.1% | −60.0% | 83.9% | 102.0% | 26.9% | 36.9% | 123.9% | −17.1% | −84.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 126 | 124 | 146 | 178 | 195 | 220 | 214 | 235 | 216 | 314 | 433 | 471 |
| Inventory days | 216 | 162 | 193 | 194 | 121 | 124 | 73 | 119 | 109 | 47 | 30 | 32 |
| Days payable | 248 | 197 | 244 | 258 | 220 | 251 | 272 | 316 | 302 | 585 | 728 | 496 |
| Cash conversion cycle | 95 | 90 | 95 | 115 | 97 | 95 | 16 | 38 | 23 | −224 | −264 | 8 |
| Working capital days | 181 | 96 | 119 | 150 | 154 | 163 | 118 | 165 | 150 | 110 | 176 | 327 |
| ROCE % | 2.6% | 6.0% | 5.4% | 5.8% | 6.1% | 5.4% | 6.4% | 6.5% | 7.1% | 6.9% | 6.9% | 6.6% |
For the Mar 2026 quarter, Desh Rakshak Aushdhalaya reported sales of ₹3.44 Cr, down 21.5% year on year and net profit of ₹0.29 Cr, down 17.1% year on year. The operating margin was 18.2%.
Desh Rakshak Aushdhalaya's sales for the year to Mar 2026 were ₹7.09 Cr; over the last twelve months they were ₹7.06 Cr.
Net profit for the year to Mar 2026 was ₹0.55 Cr, and ₹0.53 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.10.
Desh Rakshak Aushdhalaya reported borrowings of ₹2.79 Cr at Mar 2026, against cash and equivalents of ₹0.16 Cr.
Cash from operations was −₹1.30 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹2.82 Cr.